Eli Lilly

HIRING · 1 OPEN AI

About

At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determi...

Eli Lilly

About

Updates & Highlights

Echostar, Enbridge, Rivian, Samsara, Eli Lilly Trending

Eli Lilly’s Leading Position in the Weight-Loss Drug Market Remains Solid, Competition Landscape for Oral Drugs Begins to Emerge

What Would It Take For Eli Lilly Stock To Keep Climbing?

Recent Openings

Scientific Lead - Forward Deployed AI Engineer, Applied Intelligence for Discovery

All Jobs

Scientific Lead - Forward Deployed AI Engineer, Applied Intelligence for Discovery

Culture & Mission

Benefits & Perks

Equity/Stock Options

Health Insurance

Remote Work

Learning Budget

Generous PTO

401(k) Match

Tech Stack

Core Values

Innovation

Collaboration

Excellence

Impact

Office Locations

Team

Are you on the team at Eli Lilly?

News & Press

Echostar, Enbridge, Rivian, Samsara, Eli Lilly Trending

Eli Lilly’s Leading Position in the Weight-Loss Drug Market Remains Solid, Competition Landscape for Oral Drugs Begins to Emerge

What Would It Take For Eli Lilly Stock To Keep Climbing?

Can Eli Lilly’s Two-Drug Obesity Treatment Justify Its $1 Trillion Valuation?

Can Eli Lilly’s Two-Drug Obesity Treatment Justify Its $1 Trillion Valuation?

Eli Lilly escalates oral SERD battle with FDA approval for Inluriyo, Verzenio combo

Better Buy for Cautious Investors: Eli Lilly vs Costco

Eli Lilly (LLY) Gets a Big Price Target Boost, Analysts See 20% Upside

Novo Nordisk (NVO) and Eli Lilly (LLY)’s Weight-Loss Drugs Still Work at Smaller Doses, Study Finds

Goldman Sachs Adjusts Eli Lilly Price Target to $1,371 From $1,367, Maintains Buy Rating

This Trend is Excellent News for Eli Lilly and Its Investors

This Trend is Excellent News for Eli Lilly and Its Investors

Companies illegally selling unapproved Eli Lilly weight loss drug Retatrutide online

Eli Lilly and QurCan sign genetic medicine deal

Twist Bioscience stock rises on Eli Lilly partnership deal

Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It

Eli Lilly (LLY) Stock Could Be A Bargain At This Price

Eli Lilly's Momentum Looks Unstoppable -- but 1 Factor Could Change Everything

Why One of the Last Eli Lilly Holdouts Just Upgraded the Stock to Buy

Eli Lilly To Present Fresh Data On Foundayo, Retatrutide In Europe – Here’s Why Berenberg Sees A 21% Potential Upside In LLY Stock